hurricane_maria

Devastation to Puerto Rico threatens global medicine supply

September 27, 2017
Medical Communications, Research and Development Puerto Rico, biotech, drugs, pharma, pharmaceutical

The destructive forces of Hurricane Maria have caused untold damage to the island nation, with a reported 13 people left …

brainss

Axovant shares capitulate after Alzheimer’s drug failure

September 26, 2017
Research and Development Alzheimer's, Axovant, biotech, drugs, pharma, pharmaceutical

Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …

online_version

New CMO hops onto Bicycle Therapeutics

September 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …

tessa_hilado-web-aug2017-allergan

Allergan’s Executive VP and Chief Financial Officer steps down

September 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …

FDA pointedly rejects Intellipharma’s opioid painkiller

September 26, 2017
Manufacturing and Production, Sales and Marketing FDA, Intellipharma, biotech, drugs, pharma, pharmaceutical

The FDA has been very public in its stance that it will look to gain the upper hand in bringing …

shutterstock_95714119

Cancer trials underrepresent minorities and elderly, Mayo Clinic says

September 26, 2017
Manufacturing and Production, Research and Development clinical trials, pharma, pharmaceutical

New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic …

image_credit_interpol

Pangea X: the largest coordinated operation against counterfeit drugs

September 26, 2017
Manufacturing and Production, Sales and Marketing Europol, FDA, biotech, drugs, interpol, pharma, pharmaceutical

Operation Pangea X represents an anniversary, of sorts – as it stands as the 10th year of operations by Interpol …

Pfizer sets up its own biotech to develop rejected drugs

September 26, 2017
Manufacturing and Production, Sales and Marketing Pfizer, SpringWorks Therapeutics, biotech, drugs, pharma, pharmaceutical

Pfizer has moved to set up an entirely independent company to develop four of its own clinical-stage drug candidates. The …

shutterstock_57369385

Refining the system: Improving patients’ access to medicine

September 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …

allergan

Allergan posts disappointing data in NASH

September 25, 2017
Research and Development, Sales and Marketing Allergan, biotech, drugs, nash, pharma, pharmaceutical

It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …

Sanofi’s arthritis treatment Kevzara secures NICE recommendation

September 25, 2017
Sales and Marketing Kevzara, NICE, Sanofi, pharma, pharmaceutical, rheumatoid arthritis, sarilumab

Sanofi, along with its speciality care global business unit Sanofi Genzyme, are celebrating the news that NICE has passed its …

aedes_aegypti_during_blood_meal

‘Super malaria’ sweeps South East Asia

September 25, 2017
Medical Communications, Sales and Marketing biotech, drug resistance, drug-resistance, drugs, malaria, pharma, pharmaceutical

There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that …

shutterstock_235920349

Indivior reaches settlement with Mylan over patent dispute

September 25, 2017
Sales and Marketing Mylan, indivior, patent, pharma, pharmaceutical, suboxone

Indivior has ended a patent dispute with Mylan concerning its heroin addiction therapy Suboxone (buprenorphine and naloxone) sublingual film by …

jj_2johnson_and_johnson

FDA rejects J&J’s treatment for rheumatoid arthritis

September 25, 2017
Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, sirukumab

Perhaps unsurprisingly, after the FDA’s advisory committee had voted 12-1 against approval of Johnson & Johnson’s drug, the FDA returned …

alnylam

Alnylam soars on likely first RNAi treatment approval

September 22, 2017
Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …

fda_building_web

19 deaths from liver drug causes Intercept shares to tumble

September 22, 2017
Medical Communications, Sales and Marketing Intercept Pharmaceuticals, Ocliva, biotech, drugs, pharma, pharmaceutical

Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a …

NICE recommends Bayer’s Eylea for myopic chorodial neovascularisation

September 22, 2017
Medical Communications, Sales and Marketing Bayer, Eylea, NICE, pharma, pharmaceutical

Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution …

New therapy offers triple threat to HIV virus

September 22, 2017
Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …

The Gateway to Local Adoption Series

Latest content